EcoDrugPlus

Tyrosine Kinase 2

Ensembl ID : ENSPVAG00000003691
Gene Symbol: TYK2
1 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSPVAG00000011456
Gene Symbol: TIE1
1 Cross references
203 Possible Orthologues:

Utrophin

Ensembl ID : ENSPVAG00000003772
Gene Symbol: UTRN
1 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSPVAG00000003322
Gene Symbol: VEGFA
1 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSPVAG00000011085
Gene Symbol: VDR
1 Cross references
458 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSPVAG00000007119
Gene Symbol: XDH
1 Cross references
211 Possible Orthologues:

Ensembl ID : ENSPVAG00000016250
Gene Symbol: -
Cross references: -
230 Possible Orthologues:

Ensembl ID : ENSPVAG00000016346
Gene Symbol: -
Cross references: -
390 Possible Orthologues:

Ensembl ID : ENSPVAG00000006882
Gene Symbol: -
Cross references: -
246 Possible Orthologues:

Ensembl ID : ENSPVAG00000006792
Gene Symbol: -
Cross references: -
236 Possible Orthologues:

Ensembl ID : ENSPVAG00000004196
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSPVAG00000008587
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).